ProMIS Neurosciences, Inc. (PMN)
$9.61+5.03%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $13M
- Beta
- -0.22
- P/E (TTM)
- -0.55
- Short % float
- 28.46%
- Days to cover
- 7.1
- SI change
- -0.6%
- 1W
- +2.23%
- 1M
- -28.28%
- vs SPY 1W
- +1.07%
- vs SPY 1M
- -31.28%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PMN?
- LOPJLB’s latest quantitative signal on ProMIS Neurosciences, Inc. (PMN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PMN in?
- ProMIS Neurosciences, Inc. (PMN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does ProMIS Neurosciences, Inc. (PMN) do?
- ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to iden…